A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2019-07-19
- Lead Sponsor
- Pharmathen S.A.
- Target Recruit Count
- 70
- Registration Number
- NCT03425552
- Locations
- π―π΄
Al-Esraa Hospital, Amman, Jordan
π―π΄King Abdullah University Hospital, Ar Ramtha, Jordan
π―π΄Princes Basma Teaching Hospital, Irbid, Jordan
Β© Copyright 2025. All Rights Reserved by MedPath